Inhibitors based on fusion, HR1 and HR2 sequences in bacterial adhesin

Details for Australian Patent Application No. 2005261358 (hide)

Owner Chiron SRL

Inventors Masignani, Vega

Agent FB Rice

Pub. Number AU-A-2005261358

PCT Pub. Number WO2006/006074

Priority 0415160.1 06.07.04 GB

Filing date 6 July 2005

Wipo publication date 19 January 2006

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/095 (2006.01) Medicinal preparations containing antigens or antibodies - Neisseria

A61K 39/102 (2006.01) Medicinal preparations containing antigens or antibodies - Pasteurella

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07K 7/00 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 14/22 (2006.01) Peptides having more than 20 amino acids

C07K 14/285 (2006.01) Peptides having more than 20 amino acids

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 1/20 (2006.01) Micro-organisms, e.g. protozoa - Bacteria

Event Publications

1 February 2007 PCT application entered the National Phase

  PCT publication WO2006/006074 Priority application(s): WO2006/006074

11 December 2008 Alteration of Name

  The name of the applicant has been altered to Novartis Vaccines and Diagnostics SRL

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005261360-Low-power reconfigurable architecture for simultaneous implementation of distinct communication standards

2005261356-Methods for predicting therapeutic response to agents acting on the growth hormone receptor